These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24247143)

  • 1. A type III secretion system inhibitor targets YopD while revealing differential regulation of secretion in calcium-blind mutants of Yersinia pestis.
    Jessen DL; Bradley DS; Nilles ML
    Antimicrob Agents Chemother; 2014; 58(2):839-50. PubMed ID: 24247143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YopD of Yersinia pestis plays a role in negative regulation of the low-calcium response in addition to its role in translocation of Yops.
    Williams AW; Straley SC
    J Bacteriol; 1998 Jan; 180(2):350-8. PubMed ID: 9440524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
    Francis MS; Lloyd SA; Wolf-Watz H
    Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.
    Duncan MC; Wong WR; Dupzyk AJ; Bray WM; Linington RG; Auerbuch V
    Antimicrob Agents Chemother; 2014; 58(2):1118-26. PubMed ID: 24295981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Yersinia pestis type III secretion needle plays a role in the regulation of Yop secretion.
    Torruellas J; Jackson MW; Pennock JW; Plano GV
    Mol Microbiol; 2005 Sep; 57(6):1719-33. PubMed ID: 16135236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LcrQ Coordinates with the YopD-LcrH Complex To Repress
    Fei K; Yan H; Zeng X; Huang S; Tang W; Francis MS; Chen S; Hu Y
    mBio; 2021 Jun; 12(3):e0145721. PubMed ID: 34154409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissection of homologous translocon operons reveals a distinct role for YopD in type III secretion by Yersinia pseudotuberculosis.
    Bröms JE; Forslund AL; Forsberg Å; Francis MS
    Microbiology (Reading); 2003 Sep; 149(Pt 9):2615-2626. PubMed ID: 12949185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression hierarchy in the Yersinia type III secretion system established through YopD recognition of RNA.
    Chen Y; Anderson DM
    Mol Microbiol; 2011 May; 80(4):966-80. PubMed ID: 21481017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
    Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
    Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.
    Costa TR; Edqvist PJ; Bröms JE; Ahlund MK; Forsberg A; Francis MS
    J Biol Chem; 2010 Aug; 285(33):25269-84. PubMed ID: 20525687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
    Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
    Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SycN/YscB chaperone-binding domain of YopN is required for the calcium-dependent regulation of Yop secretion by Yersinia pestis.
    Joseph SS; Plano GV
    Front Cell Infect Microbiol; 2013; 3():1. PubMed ID: 23355975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa.
    Zetterström CE; Hasselgren J; Salin O; Davis RA; Quinn RJ; Sundin C; Elofsson M
    PLoS One; 2013; 8(12):e81969. PubMed ID: 24324737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.
    Solomon R; Zhang W; McCrann G; Bliska JB; Viboud GI
    PLoS One; 2015; 10(3):e0120471. PubMed ID: 25807250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Disk Diffusion Assay on Magnesium Oxalate Agar To Evaluate the Susceptibility of Yersinia pestis to Type III Secretion System Inhibitors.
    Prashar S; Portales Guemes M; Shivbaran P; Jimenez Alvarez E; Soha C; Nacer S; McDonough M; Plano GV; Torruellas Garcia J
    Microbiol Spectr; 2021 Sep; 9(1):e0000521. PubMed ID: 34132578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the low-calcium response in Yersinia pestis via plasmid-plasmid interaction.
    Sample AK; Fowler JM; Brubaker RR
    Microb Pathog; 1987 Jun; 2(6):443-53. PubMed ID: 3507558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis.
    Harmon DE; Davis AJ; Castillo C; Mecsas J
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3241-54. PubMed ID: 20498321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.